A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
Clinical trial NCT01500538 · TERMINATED
Trial details
- NCT number
- NCT01500538
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.